Skip to content
Brand AI

Merck Serono

Recent events

Recent events tied to this brand in public sources.

Back to profile1 entries

  1. 2020

    FDA approves BAVENCIO for first-line maintenance treatment

    The US FDA approved the supplemental Biologics License Application for BAVENCIO for maintenance treatment of certain patients with locally advanced or metastatic urothelial carcinoma whose disease had not progressed with first-line platinum-containing chemotherapy.

    Source